Skip to main content

UCI MIND Director speaks on AAIC panel about impact and ethics of Aduhelm approval

By July 27, 2021Commentary, In the News
UCI MIND Director, Joshua Grill, PhD spoke today as part of a panel on the impact of drug approval on future clinical trials at the AAIC Annual Conference in Denver, CO. Dr. Grill presented on the ethical considerations needed for designing studies in the presence of an approved drug like Aduhelm.
 To learn more about this topic, read the recent paper he co-authored with Dr. Jason Karlawish in Neurology